Aurobindo Pharma gets USFDA nod for Nafcillin
New Delhi, Dec 27 (PTI) Drug firm Aurobindo Pharma today said it has received final approval by the US health regulator to manufacture and market Nafcillin for injection used for treating bacterial infections in the American market.
The company has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Nafcillin for injection USP, packaged in 1g and 2g vials and Nafcillin for injection USP 10g/vial pharmacy bulk package, Aurobindo Pharma said in a statement.
The company has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Nafcillin for injection USP, packaged in 1g and 2g vials and Nafcillin for injection USP 10g/vial pharmacy bulk package, Aurobindo Pharma said in a statement.
0 comments:
Post a Comment